about
IGRhCellID: integrated genomic resources of human cell lines for identificationMolecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesMetabolic, autophagic, and mitophagic activities in cancer initiation and progressionCross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and DiseaseHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesMitochondria and the autophagy-inflammation-cell death axis in organismal agingTumor suppressor and hepatocellular carcinomaChronic Deletion and Acute Knockdown of Parkin Have Differential Responses to Acetaminophen-induced Mitophagy and Liver Injury in MiceCancer and neurodegeneration: between the devil and the deep blue sea.Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cellsDiscovering tumor suppressor genes through genome-wide copy number analysis.Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis.Activins and follistatins: Emerging roles in liver physiology and cancerAbnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.Common fragile site tumor suppressor genes and corresponding mouse models of cancer.The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and CancerTissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinomaEmerging drugs for hepatocellular carcinoma.Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation.The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age.Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease.New targeted approaches against the ubiquitin-proteasome system in gastrointestinal malignancies.Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.An emerging role of PARK2 in cancer.The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma.Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.Post translational modification of Parkin.Nuclear accumulation of seven in absentia homologue-2 supports motility and proliferation of liver cancer cells.alpha-Synuclein stimulates differentiation of osteosarcoma cells: relevance to down-regulation of proteasome activity.Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.Parkin induces upregulation of 40S ribosomal protein SA and posttranslational modification of cytokeratins 8 and 18 in human cervical cancer cells.Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response.Parkin gene alterations in ovarian carcinoma from northern Indian population.Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation.RORA, a large common fragile site gene, is involved in cellular stress response.Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.Mechanisms, pathophysiological roles and methods for analyzing mitophagy - recent insights.Parkin protein expression and its impact on survival of patients with advanced colorectal cancer.
P2860
Q24614535-BE939234-57F7-4192-995A-1B94F4D8CC26Q26745338-41B5339A-6BD0-4261-ABB9-377D661B628CQ26745503-A1110CBD-7AD8-4F24-B095-7A2477AF619DQ26765684-CD63974F-5614-46ED-B64F-D4BCAB7953E5Q26772317-4B5FD13E-94BA-4E2D-99AC-7FF34DABDF66Q26995343-CD28C699-67AD-42D2-A27F-600BD5267370Q28389231-4304725E-30B6-4762-9927-D8EBF6807671Q28392505-40AE4083-3037-4D2D-8761-2DCB0638EE08Q33784620-B596C7B7-97B0-4DBF-A2E0-239204566DCAQ34121525-68A85C9E-7308-427F-8EB8-20D102A2E9B0Q34152841-FE995850-D6FA-4FE1-8541-964D206516C9Q34359802-CADFDBB1-DC9D-4586-9732-1A7263A26A8FQ34391497-16DFC226-ED5F-44B3-8CA1-709904BDE267Q34467458-5A396E96-30AD-45F3-AD1C-8EB2E6D09238Q34557827-4E53C57F-1A0A-422B-821A-9A32E15BA222Q34576070-753CFFB6-3D47-4D6B-BDB0-76E381CB84A3Q34605140-8B154CB0-D5A0-4685-A91E-C8E345E669EAQ36580595-6D89BCA2-9796-4FE6-993E-DD498AFE68C9Q36823704-10A985BA-9646-4DF9-BE06-EEA03417FF86Q36953585-DEF29D59-DC32-4D33-8E52-8BA2D01DF4BAQ37386688-0B3C4FA8-DAA3-4DEB-878E-7A06D93AAD07Q37536837-D30B93FE-F154-4D8D-8B00-E804499D9A6FQ38002469-DB257A43-DCBD-4872-9DF6-6C8FFE0A77A6Q38021865-0C524E52-067C-458F-9B1F-5498A617EF2DQ38168127-D62CF942-0214-4FA5-A1CD-23D373ECE883Q38178169-BB4CD43D-7901-43E7-B067-4913CD489282Q39009613-5877D2CD-9CDD-4871-A465-215B5188BCFBQ39145536-FFCC7C2C-AD1F-4637-BE6E-E0717DB3E34BQ39398502-BF8E4596-6D8F-4F3F-812C-D92E6BC86502Q40190309-D462F3BC-D687-483A-A057-8426F1853FADQ41651606-73169620-3685-49C1-9D01-B1811BBD99F9Q42273308-FC2AD782-9345-4077-8FAC-C48916BDE5D5Q42426458-0998003E-49FB-4C21-9732-1188BE2BF348Q44281189-58E61C79-3D4F-46C0-84F3-FDAC364B764DQ45923538-025501F8-66E6-4BEF-9B63-2F8D021FE7DAQ46402658-76C68858-D9AE-4CB9-84BC-E7CADC65C0FBQ46931410-8AE8BEC4-CAEC-4DAE-860E-CCA977F4B514Q48593906-005846A3-87A7-4A8F-921D-1B9B78BE5F89Q49612593-AA23A57D-10E7-4743-AAD6-FCE49551FDE5Q55226339-1D1FAD7C-0605-400A-8EB9-E890B6C3C6D9
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Parkin gene alterations in hepatocellular carcinoma.
@en
type
label
Parkin gene alterations in hepatocellular carcinoma.
@en
prefLabel
Parkin gene alterations in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Parkin gene alterations in hepatocellular carcinoma.
@en
P2093
Birgitt Schüle
Damien Montoya
David I Smith
Jin-Ping Lai
Leslie A Philips
Norman Kock
Stacy Denison
Viji Shridhar
P2860
P356
10.1002/GCC.20020
P577
2004-06-01T00:00:00Z